Skip to main content
    • Aa
    • Aa
  • Access
  • Open access
  • Cited by 66
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Catalan-Figueroa, Johanna Palma-Florez, Sujey Alvarez, Gonzalo Fritz, Hans F Jara, Miguel O and Morales, Javier O 2016. Nanomedicine and nanotoxicology: the pros and cons for neurodegeneration and brain cancer. Nanomedicine, Vol. 11, Issue. 2, p. 171.

    Costa, Lia Amaral, Cristina Teixeira, Natércia Correia-da-Silva, Georgina and Fonseca, Bruno M. 2016. Cannabinoid-induced autophagy: Protective or death role?. Prostaglandins & Other Lipid Mediators, Vol. 122, p. 54.

    El-Khoury, Victoria and Berchem, Guy 2016. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging.

    Ha, Joohun and Kim, Joungmok 2016. Novel pharmacological modulators of autophagy: an updated patent review (2012-2015). Expert Opinion on Therapeutic Patents, p. 1.

    Jakhar, Rekha Paul, Souren Bhardwaj, Monika and Kang, Sun Chul 2016. Astemizole–Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis. Cancer Letters, Vol. 372, Issue. 1, p. 89.

    Lin, Yi-Chia Lin, Ji-Fan Wen, Sheng-I Yang, Shan-Che Tsai, Te-Fu Chen, Hung-En Chou, Kuang-Yu and Hwang, Thomas I-Sheng 2016. Inhibition of High Basal Level of Autophagy Induces Apoptosis in Human Bladder Cancer Cells. The Journal of Urology, Vol. 195, Issue. 4, p. 1126.

    Paz Hernandez, Maria Oses, Carolina Peña, Daniel Criollo, Alfredo and Morselli, Eugenia 2016. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging.

    Sallman, David A. Cluzeau, Thomas Basiorka, Ashley A. and List, Alan 2016. Unraveling the Pathogenesis of MDS: The NLRP3 Inflammasome and Pyroptosis Drive the MDS Phenotype. Frontiers in Oncology, Vol. 6,

    Shen, Bing Tan, Mingyue Mu, Xinyu Qin, Yan Zhang, Fang Liu, Yong and Fan, Yu 2016. Upregulated SMYD3 promotes bladder cancer progression by targeting BCLAF1 and activating autophagy. Tumor Biology, Vol. 37, Issue. 6, p. 7371.

    Ko, Chung-Po Lin, Chiao-Wen Chen, Mu-Kuan Yang, Shun-Fa Chiou, Hui-Ling and Hsieh, Ming-Ju 2015. Pterostilbene induce autophagy on human oral cancer cells through modulation of Akt and mitogen-activated protein kinase pathway. Oral Oncology, Vol. 51, Issue. 6, p. 593.

    Liu, Emma Y. Xu, Naihan O’Prey, Jim Lao, Laurence Y. Joshi, Sanket Long, Jaclyn S. O’Prey, Margaret Croft, Daniel R. Beaumatin, Florian Baudot, Alice D. Mrschtik, Michaela Rosenfeldt, Mathias Zhang, Yaou Gillespie, David A. and Ryan, Kevin M. 2015. Loss of autophagy causes a synthetic lethal deficiency in DNA repair. Proceedings of the National Academy of Sciences, Vol. 112, Issue. 3, p. 773.

    Michels, J. Yamasaki, T. and Apetoh, L. 2015. Immunogénicité de la chimiothérapie. Oncologie, Vol. 17, Issue. 9, p. 345.

    Pal, Ipsita Parida, Sheetal Prashanth Kumar, B.N. Banik, Payel Kumar Dey, Kaushik Chakraborty, Sandipan Bhutia, Sujit K and Mandal, Mahitosh 2015. Blockade of autophagy enhances proapoptotic potential of BI-69A11, a novel Akt inhibitor, in colon carcinoma. European Journal of Pharmacology, Vol. 765, p. 217.

    Petrova, Varvara Mancini, Mara Agostini, Massimiliano Knight, Richard A Annicchiarico-Petruzzelli, Margherita Barlev, Nikolai A Melino, Gerry and Amelio, Ivano 2015. TAp73 transcriptionally represses BNIP3 expression. Cell Cycle, Vol. 14, Issue. 15, p. 2484.

    Tang, Juanjuan Di, Jiehui Cao, Huan Bai, Jin and Zheng, Junnian 2015. p53-mediated autophagic regulation: A prospective strategy for cancer therapy. Cancer Letters, Vol. 363, Issue. 2, p. 101.

    Wang, Xiangdong Zhang, Jianghong Fu, Jiamei Wang, Juan Ye, Shuang Liu, Weili and Shao, Chunlin 2015. Role of ROS-mediated autophagy in radiation-induced bystander effect of hepatoma cells. International Journal of Radiation Biology, Vol. 91, Issue. 5, p. 452.

    Wesselborg, Sebastian and Stork, Björn 2015. Autophagy signal transduction by ATG proteins: from hierarchies to networks. Cellular and Molecular Life Sciences, Vol. 72, Issue. 24, p. 4721.

    Xu, Dong-Wei Zhang, Guan-Qing Wang, Zong-Wei Xu, Xiao-Yin and Liu, Tong-Xiang 2015. Autophagy in Tumorigenesis and Cancer Treatment. Asian Pacific Journal of Cancer Prevention, Vol. 16, Issue. 6, p. 2167.

    Zhou, Jing Li, Guobing Zheng, Yi Shen, Han-Ming Hu, Xiaoye Ming, Qian-Liang Huang, Cheng Li, Peng and Gao, Ning 2015. A novel autophagy/mitophagy inhibitor liensinine sensitizes breast cancer cells to chemotherapy through DNM1L-mediated mitochondrial fission. Autophagy, Vol. 11, Issue. 8, p. 1259.

    Elgendy, Mohamed Ciro, Marco Abdel-Aziz, Amal Kamal Belmonte, Giuseppe Zuffo, Roberto Dal Mercurio, Ciro Miracco, Clelia Lanfrancone, Luisa Foiani, Marco and Minucci, Saverio 2014. Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner. Nature Communications, Vol. 5, p. 5637.

  • Expert Reviews in Molecular Medicine, Volume 11
  • 2009, e36

The role of autophagy in tumour development and cancer therapy

  • Mathias T. Rosenfeldt (a1) and Kevin M. Ryan (a1)
  • DOI:
  • Published online: 01 December 2009

Autophagy is a catabolic membrane-trafficking process that leads to sequestration and degradation of intracellular material within lysosomes. It is executed at basal levels in every cell and promotes cellular homeostasis by regulating organelle and protein turnover. In response to various forms of cellular stress, however, the levels and cargoes of autophagy can be modulated. In nutrient-deprived states, for example, autophagy can be activated to degrade cargoes for cell-autonomous energy production to promote cell survival. In other contexts, in contrast, autophagy has been shown to contribute to cell death. Given these dual effects in regulating cell viability, it is no surprise that autophagy has implications in both the genesis and treatment of malignant disease. In this review, we provide a comprehensive appraisal of the way in which oncogenes and tumour suppressor genes regulate autophagy. In addition, we address the current evidence from human cancer and animal models that has aided our understanding of the role of autophagy in tumour progression. Finally, the potential for targeting autophagy therapeutically is discussed in light of the functions of autophagy at different stages of tumour progression and in normal tissues.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the or variations. ‘’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The role of autophagy in tumour development and cancer therapy
      Available formats
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      The role of autophagy in tumour development and cancer therapy
      Available formats
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      The role of autophagy in tumour development and cancer therapy
      Available formats
Re-use permitted under a Creative Commons Licence–by-nc-sa.
Corresponding author
*Corresponding author: Kevin M. Ryan, Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Glasgow, G61 1BD, UK. Tel: +44 1413 303655; Fax: +44 1419 426521; E-mail:
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1J.J. Lum (2005) Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248

2J.J. Lum , R.J. DeBerardinis and C.B. Thompson (2005) Autophagy in metazoans: cell survival in the land of plenty. Nature Reviews Molecular Cell Biology 6, 439-448

3A. Kuma (2004) The role of autophagy during the early neonatal starvation period. Nature 432, 1032-1036

4N. Mizushima (2008) Autophagy fights disease through cellular self-digestion. Nature 451, 1069-1075

5M.C. Maiuri (2009) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death and Differentiation 16, 87-93

6M.C. Maiuri (2007) Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nature Reviews Molecular Cell Biology 8, 741-752

7A.R.J. Young (2009) Autophagy mediates the mitotic senescence transition. Genes and Development 23, 798-803

8Y. Kondo (2005) The role of autophagy in cancer development and response to therapy. Nature Reviews Cancer 5, 726-734

9E-L. Eskelinen (2005) Maturation of autophagic vacuoles in Mammalian cells. Autophagy 1, 1-10

10Z. Xie and D.J. Klionsky (2007) Autophagosome formation: core machinery and adaptations. Nature Cell Biology 9, 1102-1109

11B. Levine and G. Kroemer (2008) Autophagy in the pathogenesis of disease. Cell 132, 27-42

12S. Diaz-Troya (2008) The role of TOR in autophagy regulation from yeast to plants and mammals. Autophagy 4, 851-865

13T. Hara (2008) FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. Journal of Cell Biology 181, 497-510

14C.H. Jung (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Molecular Biology of the Cell 20, 1992-2003

15I.G. Ganley (2009) ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. Journal of Biological Chemistry 284, 12297-12305

16C. Liang (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nature Cell Biology 8, 688-699

17C. Liang (2008) Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nature Cell Biology 10, 776-787

18Y. Ohsumi and N. Mizushima (2004) Two ubiquitin-like conjugation systems essential for autophagy. Seminars in Cell and Developmental Biology 15, 231-236

20Y. Kabeya (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO Journal 19, 5720-5728

21D.J. Klionsky (2008) Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175

22Z. Xie , U. Nair and D.J. Klionsky (2008) Atg8 controls phagophore expansion during autophagosome formation. Molecular Biology of the Cell 19, 3290-3298

23Z. Yang (2006) Atg22 recycles amino acids to link the degradative and recycling functions of autophagy. Molecular Biology of the Cell 17, 5094-5104

24D. Hanahan and R.A. Weinberg (2000) The hallmarks of cancer. Cell 100, 57-70

25R. Mathew , V. Karantza-Wadsworth and E. White (2007) Role of autophagy in cancer. Nature Reviews Cancer 7, 961-967

26R. Mathew (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075

27V. Karantza-Wadsworth (2007) Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes and Development 21, 1621-1635

28R. Mathew (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes and Development 21, 1367-1381

29S. Jin and E. White (2007) Role of autophagy in cancer: management of metabolic stress. Autophagy 3, 28-31

30A. Eisenberg-Lerner and A. Kimchi (2009) The paradox of autophagy and its implication in cancer etiology and therapy. Apoptosis 14, 376-391

31V.M. Aita (1999) Cloning and genomic organization of beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics 59, 59-65

34X. Qu (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. Journal of Clinical Investigation 112, 1809-1820

36M. Komatsu (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. Journal of Cell Biology 169, 425-434

37T. Hara (2006) Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889

38G. Mariño (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. Journal of Biological Chemistry 282, 18573-18583

39M.S. Kim (2008) Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Human Pathology 39, 1059-1063

40M.R. Kang (2009) Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. Journal of Pathology 217, 702-706

41Y. Takahashi (2007) Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nature Cell Biology 9, 1142-1151

42E. Morselli (2009) Anti- and pro-tumor functions of autophagy. Biochimica et Biophysica Acta 1793, 1524-1532

43S. Pattingre (2008) Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90, 313-323

44P.K. Vogt , M. Gymnopoulos and J.R. Hart (2009) PI 3-kinase and cancer: changing accents. Current Opinion in Genetics and Development 19, 12-17

45D.E. Martin and M.N. Hall (2005) The expanding TOR signaling network. Current Opinion in Cell Biology 17, 158-166

46D.H. Kim (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175

47D.D. Sarbassov (2004) Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Current Biology 14, 1296-1302

48D.D. Sarbassov (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101

49A. Toschi (2008) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. Journal of Biological Chemistry 283, 34495-34499

50D.A. Guertin and D.M. Sabatini (2007) Defining the role of mTOR in cancer. Cancer Cell 12, 9-22

51B. Levine , S. Sinha and G. Kroemer (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600-606

52M.C. Maiuri (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO Journal 26, 2527-2539

53S. Pattingre (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939

54E. Itakura (2008) Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Molecular Biology of the Cell 19, 5360-5372

56Y. Zhong (2009) Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nature Cell Biology 11, 468-476

57K. Matsunaga (2009) Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nature Cell Biology 11, 385-396

59T.L. Yuan and L.C. Cantley (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510

60V.P. Krymskaya and E.A. Goncharova (2009) PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle 8, 403-413

61R.J. Shaw and L.C. Cantley (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441, 424-430

62S. Furuta (2004) Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 23, 3898-3904

63E. Ogier-Denis (2000) Erk1/2-dependent phosphorylation of Galpha-interacting protein stimulates its GTPase accelerating activity and autophagy in human colon cancer cells. Journal of Biological Chemistry 275, 39090-39095

64S. Pattingre , C. Bauvy and P. Codogno (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. Journal of Biological Chemistry 278, 16667-16674

65E. Corcelle (2006) Disruption of autophagy at the maturation step by the carcinogen lindane is associated with the sustained mitogen-activated protein kinase/extracellular signal-regulated kinase activity. Cancer Research 66, 6861-6870

66J. Wang (2009) A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. Journal of Biological Chemistry 284, 21412-21424

67A.K. Rustgi (2007) The genetics of hereditary colon cancer. Genes and Development 21, 2525-2538

68J. Liang (2007) The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nature Cell Biology 9, 218-224

69C. Wei (2008) Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling. Clinical Cancer Research 14, 1167-1171

70D. Gozuacik and A. Kimchi (2006) DAPk protein family and cancer. Autophagy 2, 74-79

71E. Zalckvar (2009) DAP-kinase-mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl-XL and induction of autophagy. EMBO Reports 10, 285-292

72C. Stevens (2009) Peptide combinatorial libraries identify TSC2 as a death-associated protein kinase (DAPK) death domain-binding protein and reveal a stimulatory role for DAPK in mTORC1 signaling. Journal of Biological Chemistry 284, 334-344

73Y. Yu (2003) Epigenetic regulation of ARHI in breast and ovarian cancer cells. Annals of the New York Academy of Sciences 983, 268-277

75P. Hainaut and M. Hollstein (2000) p53 and human cancer: the first ten thousand mutations. Advances in Cancer Research 77, 81-137

77D. Crighton (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134

78Z. Feng (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proceedings of the National Academy of Sciences of the United States of America 102, 8204-8209

79E. Tasdemir (2008) Regulation of autophagy by cytoplasmic p53. Nature Cell Biology 10, 676-687

80D. Crighton , S. Wilkinson and K.M. Ryan (2007) DRAM links autophagy to p53 and programmed cell death. Autophagy 3, 72-74

81J. O'Prey (2009) Analysis of DRAM-related proteins reveals evolutionarily conserved and divergent roles in the control of autophagy. Cell Cycle 8, 2260-2265

82D. Crighton (2007) p73 regulates DRAM-independent autophagy that does not contribute to programmed cell death. Cell Death and Differentiation 14, 1071-1079

83A.V. Budanov (2004) Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304, 596-600

84J.M. Rosenbluth (2008) A gene signature-based approach identifies mTOR as a regulator of p73. Molecular and Cellular Biology 28, 5951-5964

85A.V. Budanov and M. Karin (2008) p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460

86M.C. Maiuri (2009) Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle 8, 1571-1576

87E. Morselli (2008) Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 7, 3056-3061

88W.M. Abida and W. Gu (2008) p53-Dependent and p53-independent activation of autophagy by ARF. Cancer Research 68, 352-357

89J. Pimkina (2009) ARF induces autophagy by virtue of interaction with Bcl-xl. Journal of Biological Chemistry 284, 2803-2810

90S. Reef (2006) A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Molecular Cell 22, 463-475

91S. Courtois-Cox (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10, 459-472

92M.P. DeYoung (2008) Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes and Development 22, 239-251

93R.M. Memmott and P.A. Dennis (2009) Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cellular Signalling 21, 656-664

94J. Brugarolas (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes and Development 18, 2893-2904

95T.R. Peterson (2009) DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 137, 873-886

96S. Shimizu (2004) Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nature Cell Biology 6, 1221-1228

97L. Yu (2004) Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500-1502

99S. Yousefi (2006) Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nature Cell Biology 8, 1124-1132

100D.L. Berry and E.H. Baehrecke (2007) Growth arrest and autophagy are required for salivary gland cell degradation in Drosophila. Cell 131, 1137-1148

101X. Qu (2007) Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128, 931-946

102G. Kroemer and B. Levine (2008) Autophagic cell death: the story of a misnomer. Nature Reviews Molecular Cell Biology 9, 1004-1010

103A. Prieur and D.S. Peeper (2008) Cellular senescence in vivo: a barrier to tumorigenesis. Current Opinion in Cell Biology 20, 150-155

104T. Fehm (2008) Tumor cell dormancy: implications for the biology and treatment of breast cancer. APMIS: Acta Pathologica Microbiologica et Immunologica Scandinavica 116, 742-753

105K. Degenhardt (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64

106R.K. Amaravadi and C.B. Thompson (2007) The roles of therapy-induced autophagy and necrosis in cancer treatment. Clinical Cancer Research 13, 7271-7279

107W.X. Zong (2004) Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes and Development 18, 1272-1282

108Z. Jin (2009) Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137, 721-735

109J. Moscat and M.T. Diaz-Meco (2009) p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137, 1001-1004

110A. Duran (2008) The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13, 343-354

111R.K. Amaravadi (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. Journal of Clinical Investigation 117, 326-336

112K.H. Maclean (2008) Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis. Journal of Clinical Investigation 118, 79-88

113M. Komatsu (2006) Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884

114S. Wilkinson (2009) Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity. Genes and Development 23, 1283-1288

115S. Wilkinson and K.M. Ryan (2009) Growth factor signaling permits hypoxia-induced autophagy by a HIF1alpha-dependent, BNIP3/3L-independent transcriptional program in human cancer cells. Autophagy 5, 1068-1069

116Y. Nishida (2009) Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461, 654-659

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Expert Reviews in Molecular Medicine
  • ISSN: -
  • EISSN: 1462-3994
  • URL: /core/journals/expert-reviews-in-molecular-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *